{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:42:23Z","timestamp":1791981743388,"version":"4.4.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jbspin.2019.04.006","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T17:56:48Z","timestamp":1557338208000},"page":"131-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Structural progression in axial spondyloarthritis"],"prefix":"10.1016","volume":"87","author":[{"given":"Krystel","family":"Aouad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly","family":"Ziade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xenofon","family":"Baraliakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2019.04.006_bib0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(16)31591-4","article-title":"Axial spondyloarthritis","volume":"390","author":"Sieper","year":"2017","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0010","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1136\/annrheumdis-2012-201945","article-title":"The frequency of non-radiographic axial spondyloarthritis in relation to symptom duration in patients referred because of chronic back pain: results from the Berlin early spondyloarthritis clinic","volume":"71","author":"Poddubnyy","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0015","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0020","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0025","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1136\/annrheumdis-2013-203425","article-title":"Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiography","volume":"73","author":"Baraliakos","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0030","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nrrheum.2011.156","article-title":"The balance of tissue repair and remodeling in chronic arthritis","volume":"7","author":"Lories","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0035","doi-asserted-by":"crossref","first-page":"R104","DOI":"10.1186\/ar2496","article-title":"The relationship between inflammation and new bone formation in patients with ankylosing spondylitis","volume":"10","author":"Baraliakos","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/art.24132","article-title":"Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation","volume":"60","author":"Maksymowych","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/annrheumdis-2011-200859","article-title":"Suppression of inflammation and effects on new bone formation in ankylosing spondylitis: evidence for a window of opportunity in disease modification","volume":"72","author":"Maksymowych","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0050","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.3899\/jrheum.150250","volume":"42","author":"Buchbender","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0055","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1002\/art.39715","article-title":"Granulation tissue eroding the subchondral bone also promotes new bone formation in ankylosing spondylitis","volume":"68","author":"Bleil","year":"2016","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0060","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/annrheumdis-2017-211989","article-title":"Low-dose CT detects more progression of bone formation in comparison to conventional radiography in patients with ankylosing spondylitis: results from the SIAS cohort","volume":"77","author":"de Koning","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0065","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13075-017-1285-1","article-title":"Incorporating assessment of the cervical facet joints in the modified Stoke ankylosing spondylitis spine score is of additional value in the evaluation of spinal radiographic outcome in ankylosing spondylitis","volume":"19","author":"Maas","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0070","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1002\/art.20446","article-title":"What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the outcome measures in rheumatology clinical trials filter","volume":"50","author":"Wanders","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0075","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/art.24425","article-title":"Development of a radiographic scoring tool for ankylosing spondylitis only based on bone formation: addition of the thoracic spine improves sensitivity to change","volume":"61","author":"Baraliakos","year":"2009","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0080","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/1529-0131(199812)41:12<2263::AID-ART23>3.0.CO;2-I","article-title":"The Bath ankylosing spondylitis radiology index (basri): a new, validated approach to disease assessment","volume":"41","author":"MacKay","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0085","article-title":"National Institute of Arthritis and Metabolic Diseases (U.S.), Excerpta Medica Foundation, editors","author":"Bennett","year":"1968","journal-title":"Population studies of the rheumatic diseases; proceedings of the third international symposium, New York, June 5th-10th, 1966"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0090","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2014-206971","article-title":"EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice","volume":"74","author":"Mandl","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0095","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1136\/annrheumdis-2014-205178","article-title":"Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort","volume":"73","author":"Ramiro","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0100","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/art.33465","article-title":"Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis","volume":"64","author":"Poddubnyy","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0105","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1002\/art.22589","article-title":"Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis","volume":"56","author":"Maksymowych","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0110","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1136\/annrheumdis-2013-203824","article-title":"Elevated serum level of the vascular endothelial growth factor predicts radiographic spinal progression in patients with axial spondyloarthritis","volume":"73","author":"Poddubnyy","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0115","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1136\/annrheumdis-2014-205506","article-title":"Calprotectin serum level is an independent marker for radiographic spinal progression in axial spondyloarthritis","volume":"73","author":"Turina","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0120","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/art.38968","article-title":"Serum adipokine levels in patients with ankylosing spondylitis and their relationship to clinical parameters and radiographic spinal progression","volume":"67","author":"Syrbe","year":"2015","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0125","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1136\/ard.2010.145995","article-title":"Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis","volume":"70","author":"Poddubnyy","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0130","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.3899\/jrheum.160003","article-title":"Serum C-reactive protein levels demonstrate predictive value for radiographic and magnetic resonance imaging outcomes in patients with active ankylosing spondylitis treated with Golimumab","volume":"43","author":"Braun","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0135","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.40786","article-title":"Progression of the structural damage in the sacroiliac joints in patients with early axial spondyloarthritis during a long-term anti-TNF treatment: six-year results of the ESTHER trial","volume":"71","author":"Rios Rodriguez","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0140","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1136\/ard.2006.066415","article-title":"Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes","volume":"66","author":"Baraliakos","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0145","article-title":"Spinal radiographic progression in early axial Spondyloarthritis: five-year results from the DESIR cohort","author":"Ramiro","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0150","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1136\/annrheumdis-2017-211596","article-title":"Sacroiliac radiographic progression in recent onset axial spondyloarthritis: the 5-year data of the DESIR cohort","volume":"76","author":"Dougados","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0155","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1136\/annrheumdis-2016-209209","article-title":"High disease activity according to the Ankylosing Spondylitis Disease Activity Score is associated with accelerated radiographic spinal progression in patients with early axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort","volume":"75","author":"Poddubnyy","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0160","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s11926-011-0192-8","article-title":"The natural course of radiographic progression in ankylosing spondylitis: differences between genders and appearance of characteristic radiographic features","volume":"13","author":"Baraliakos","year":"2011","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0165","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13075-018-1665-1","article-title":"A five-year prospective study of spinal radiographic progression and its predictors in men and women with ankylosing spondylitis","volume":"20","author":"Deminger","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0170","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/annrheumdis-2017-211544","article-title":"TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort","volume":"77","author":"Molnar","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0175","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/art.38070","article-title":"The impact of tumor necrosis factor \u03b1 inhibitors on radiographic progression in ankylosing spondylitis","volume":"65","author":"Haroon","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0180","doi-asserted-by":"crossref","first-page":"e000153","DOI":"10.1136\/rmdopen-2015-000153","article-title":"Lifestyle factors may modify the effect of disease activity on radiographic progression in patients with ankylosing spondylitis: a longitudinal analysis","volume":"1","author":"Ramiro","year":"2015","journal-title":"RMD Open"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0185","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","article-title":"2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis","volume":"76","author":"van der Heijde","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0190","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/art.39298","article-title":"American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis research and treatment network 2015 recommendations for the treatment of ankylosing spondylitis and non-radiographic axial spondyloarthritis","volume":"68","author":"Ward","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0195","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1136\/annrheumdis-2012-201370","article-title":"Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis","volume":"71","author":"Kroon","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0200","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/art.21054","article-title":"Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial","volume":"52","author":"Wanders","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0205","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1136\/annrheumdis-2015-207897","article-title":"Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: results from a randomised multicentre trial (ENRADAS)","volume":"75","author":"Sieper","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0210","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1139\/bcb-2017-0267","article-title":"Effects of nonsteroidal anti-inflammatory drugs on serum proinflammatory cytokines in the treatment of ankylosing spondylitis","volume":"96","author":"Yan","year":"2018","journal-title":"Biochem Cell Biol Biochim Biol Cell"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0215","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/rheumatology\/kep393","article-title":"Clinical relevance of C-reactive protein in ankylosing spondylitis and evaluation of the NSAIDs\/coxibs\u2019 treatment effect on C-reactive protein","volume":"49","author":"Benhamou","year":"2010","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0220","first-page":"1805","article-title":"Celecoxib is efficacious and well tolerated in treating signs and symptoms of ankylosing spondylitis","volume":"33","author":"Barkhuizen","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0225","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/rheumatology\/kex081","article-title":"Non-radiographic axial spondyloarthritis patients without initial evidence of inflammation may develop objective inflammation over time","volume":"56","author":"Baraliakos","year":"2017","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0230","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/M14-2470","article-title":"Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study","volume":"163","author":"Haroon","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0235","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1002\/art.23901","article-title":"Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis","volume":"58","author":"van der Heijde","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0240","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/art.23471","article-title":"Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept","volume":"58","author":"van der Heijde","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0245","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1186\/ar2794","article-title":"Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years","volume":"11","author":"van der Heijde","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0250","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/annrheumdis-2012-202698","article-title":"Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis","volume":"73","author":"Baraliakos","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0255","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/acr.23097","article-title":"Reduction in spinal radiographic progression in ankylosing spondylitis patients receiving prolonged treatment with tumor necrosis factor inhibitors","volume":"69","author":"Maas","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0260","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/art.40661","article-title":"Impact of tumor necrosis factor inhibitor versus nonsteroidal antiinflammatory drug treatment on radiographic progression in early ankylosing spondylitis: its relationship to inflammation control during treatment","volume":"71","author":"Park","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0265","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2017-211734","article-title":"Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force","volume":"77","author":"Smolen","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0270","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41584-018-0091-8","article-title":"Effects of the IL-23-IL-17 pathway on bone in spondyloarthritis","volume":"14","author":"Gravallese","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0275","article-title":"Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 study","author":"Braun","year":"2018","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0280","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/annrheumdis-2016-209730","article-title":"Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study","volume":"76","author":"Braun","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0285","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1136\/annrheumdis-2012-203075","article-title":"The effect of two golimumab doses on radiographic progression in ankylosing spondylitis: results through 4 years of the GO-RAISE trial","volume":"73","author":"Braun","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0290","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/annrheumdis-2017-212377","article-title":"Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trial","volume":"77","author":"van der Heijde","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0295","unstructured":"ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 - . Identifier NCT03502616, Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS); 2018 June 7. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03502616."},{"key":"10.1016\/j.jbspin.2019.04.006_bib0300","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/art.40753","volume":"71","author":"Deodhar","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0305","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/S0140-6736(18)31946-9","volume":"392","author":"van der Heijde","year":"2018","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0310","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/annrheumdis-2018-eular.7889","article-title":"LB0001 Dual neutralisation of il-17a and il-17f with bimekizumab in patients with active ankylosing spondylitis (AS): 12-week results from a phase 2b, randomised, double-blind, placebo-controlled, dose-ranging study","volume":"77","author":"van der Heijde","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0315","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/S0140-6736(18)32463-2","article-title":"Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial","volume":"392","author":"van der Heijde","year":"2018","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.jbspin.2019.04.006_bib0320","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.181304","article-title":"Detection of erosions in the sacroiliac joints of patients with axial spondyloarthritis using the magnetic resonance imaging VIBE technique","author":"Baraliakos","year":"2019","journal-title":"J Rheumatol"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X19300697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X19300697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T16:26:02Z","timestamp":1761150362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X19300697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1297319X19300697"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2019.04.006","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural progression in axial spondyloarthritis","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2019.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}